Advisory Committee on Breast Cancer in Young Women (ACBCYW); Meeting, 35388-35389 [2019-15593]

Download as PDF 35388 Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices population to which generalizations will be made, the sampling frame, the sample design (including stratification and clustering), the precision requirements or power calculations that justify the proposed sample size, the expected response rate, methods for assessing potential non-response bias, the protocols for data collection, and any testing procedures that were or will be undertaken prior fielding the study. Depending on the degree of influence the results are likely to have, such collections may still be eligible for submission for other generic mechanisms that are designed to yield quantitative results. The Digital Government Strategy released by the White House in May, 2012 drives agencies to have a more customercentric focus. Because of this, GSA anticipates an increase in requests to use this generic clearance, as the plan states that: A customer-centric principle charges us to do several things: Conduct research to understand the customer’s business, needs and desires; ‘‘make content more broadly available and accessible and present it through multiple channels in a program-and device-agnostic way; make content more accurate and understandable by maintaining plain language and content freshness standards; and offer easy paths for feedback to ensure we continually improve service delivery. The customer-centric principle holds true whether our customers are internal (e.g., the civilian and military federal workforce in both classified and unclassified environments) or external (e.g., individual citizens, businesses, research organizations, and state, local, and tribal governments).’’ jspears on DSK30JT082PROD with NOTICES B. Annual Reporting Burden Respondents: 208,075. Responses per Respondent: 1. Total Annual Responses: 208,075. Hours per response: 3.8385 minutes. Total Burden hours: 13,289. C. Public Comments Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC VerDate Sep<11>2014 16:43 Jul 22, 2019 Jkt 247001 20405, telephone 202–501–4755. Please cite OMB Control No. 3090–0297, Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery, in all correspondence. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: July 16, 2019. David A. Shive, Chief Information Officer. Advisory Committee on Breast Cancer in Young Women (ACBCYW); Meeting [FR Doc. 2019–15556 Filed 7–22–19; 8:45 am] BILLING CODE 6820–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. Name of Committee: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Date: October 10–11, 2019. Time: 8:00 a.m.–5:00 p.m., EDT. Place: Embassy Suites, 1420 Stout Street, Denver, CO 80202. Agenda: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. For Further Information Contact: Nina Turner, Ph.D., Scientific Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, WV 26506, (304) 285– 5976; nturner@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–15590 Filed 7–22–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by room space, and audio web conference lines (80 audio and web conference lines available). The public is also welcome to listen to the meeting by accessing the call-in number, 1–800– 857–4868, passcode, 1218986 (80 lines are available). The web conference access is https://adobeconnect.cdc.gov/ radjn2o1shbb/. Online Registration Required: All ACBCYW Meeting participants must register for the meeting online at least 7 business days in advance at https:// www.cdc.gov/cancer/breast/what_cdc_ is_doing/conference.htm. Please complete all the required fields before submitting your registration and submit no later than August 9, 2019. All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. SUMMARY: The meeting will be held on August 19, 2019, 8:30 a.m. to 5:00 p.m., EDT and August 20, 2019, 8:30 a.m. to 12:00 Noon, EDT. ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341. The teleconference access is 1–800– 857–4868; passcode, 1218986. The web conference access is https:// adobeconnect.cdc.gov/radjn2o1shbb/. FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 5770 Buford Hwy. NE, Mailstop K52, Atlanta, Georgia, 30341, DATES: E:\FR\FM\23JYN1.SGM 23JYN1 Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices Telephone (770) 488–4518, Fax (770) 488–4760. Email: acbcyw@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters To Be Considered: The agenda will include discussions on current and emerging topics related to breast cancer in young women. These will include public health communication, breast cancer in young women digital and social media campaign, CDC updates, and updates from the field. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)– RFA–IP20–001, Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in Panama and Other Countries in the Americas. Date: August 13, 2019. Time: 10:00 a.m.–11:30 a.m., (EDT). Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329. Agenda: To review and evaluate grant applications. For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329, (404) 718–8833, gca5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–15587 Filed 7–22–19; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2019–15593 Filed 7–22–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) jspears on DSK30JT082PROD with NOTICES Notice of Closed Meeting VerDate Sep<11>2014 16:43 Jul 22, 2019 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals Jkt 247001 In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public; limited only by available seating. The meeting room accommodates approximately 78 people. Requests to make oral presentations should be submitted in writing to Gwen Mustaf, 301–458–4500, SUMMARY: PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 35389 glm4@cdc.gov, or Sayeedha Uddin, isx9@cdc.gov. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by August 14, 2019. DATES: The meeting will be held on September 5, 2019, 11:00 a.m.–5:30 p.m., EDT, and September 6, 2019, 8:30 a.m.–1:00 p.m., EDT. ADDRESSES: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458–4303, email isx9@cdc.gov. SUPPLEMENTARY INFORMATION: All visitors must be processed in accordance with established federal policies and procedures. For foreign nationals or non-U.S. citizens, preapproval is required (please contact Gwen Mustaf, 301–458–4500, glm4@ cdc.gov or Sayeedha Uddin, isx9@ cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal in international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulations, Subpart 101– 20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession of the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters To Be Considered: Day 1 meeting agenda includes welcome remarks and a Center update by NCHS leadership; update on Patient Centered Outcomes Research Trust Fund Drug Workgroup Report; update on Patient Centered Outcomes Research Trust Fund Projects; update on Evidence Based Policy Making; update on National Health Interview Survey Redesign. Day 2 meeting agenda E:\FR\FM\23JYN1.SGM 23JYN1

Agencies

[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35388-35389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15593]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW); 
Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee on Breast 
Cancer in Young Women (ACBCYW). This meeting is open to the public, 
limited only by room space, and audio web conference lines (80 audio 
and web conference lines available). The public is also welcome to 
listen to the meeting by accessing the call-in number, 1-800-857-4868, 
passcode, 1218986 (80 lines are available). The web conference access 
is https://adobeconnect.cdc.gov/radjn2o1shbb/.
    Online Registration Required: All ACBCYW Meeting participants must 
register for the meeting online at least 7 business days in advance at 
https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. 
Please complete all the required fields before submitting your 
registration and submit no later than August 9, 2019. All visitors are 
required to present a valid form of picture identification issued by a 
state, federal or international government. As required by the Federal 
Property Management Regulations, all persons entering in or on Federal 
controlled property and their packages, briefcases, and other 
containers in their immediate possession are subject to being x-rayed 
and inspected. Federal law prohibits the knowing possession or the 
causing to be present of firearms, explosives and other dangerous 
weapons and illegal substances.

DATES: The meeting will be held on August 19, 2019, 8:30 a.m. to 5:00 
p.m., EDT and August 20, 2019, 8:30 a.m. to 12:00 Noon, EDT.

ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341.
    The teleconference access is 1-800-857-4868; passcode, 1218986. The 
web conference access is https://adobeconnect.cdc.gov/radjn2o1shbb/.

FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated 
Federal Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 5770 Buford Hwy. NE, Mailstop K52, Atlanta, 
Georgia, 30341,

[[Page 35389]]

Telephone (770) 488-4518, Fax (770) 488-4760. Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters To Be Considered: The agenda will include discussions on 
current and emerging topics related to breast cancer in young women. 
These will include public health communication, breast cancer in young 
women digital and social media campaign, CDC updates, and updates from 
the field. Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-15593 Filed 7-22-19; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.